[Featured Stock] Respiratory Therapy Device Company Mecaics Up 26%

Mecics, a company specializing in respiratory therapy devices, is hitting the upper price limit.

At 10:35 AM on the 24th, Mecics is trading at 4,535 KRW, up 26.32% compared to the previous day.

This is interpreted as being influenced by the resurgence of COVID-19 in China. On the 22nd, local Chinese media reported that Chinese epidemic prevention experts predicted the peak of the second COVID-19 wave would occur by the end of next month.

Mecics is a specialized company in ventilators and respiratory therapy devices. As of the end of January, it supplied 700 units of the respiratory therapy drug HFT500 to China.